| Hunter W Davis, MD | |
|
223 Burley Ave, Hopkinsville, KY 42240 | |
| (270) 887-6565 | |
| (270) 887-6575 |
| Full Name | Hunter W Davis |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 16 Years |
| Location | 223 Burley Ave, Hopkinsville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801068861 | NPI | - | NPPES |
| 7100133790 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 44382 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Deaconess Medical Group Inc | 6103220330 | 126 |
News Archive
Asthma is the most common chronic illness and is responsible for 2.1 million emergency room visits annually. But according to a study being presented at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology, these costly visits can be reduced by 55 percent when inhalers contain a simple dose counter.
Researchers at the University of Pennsylvania School of Medicine are now studying an investigational treatment that may offer a significant new, minimally-invasive option for those suffering from advanced widespread emphysema.
Researchers at the Case Western Reserve University School of Medicine have identified that a gene critical to clearing up unnecessary proteins plays a role in brain development and contributes to the development of autism spectrum disorders and schizophrenia.
Researchers have identified a potential new signaling pathway and enzyme that may help further the understanding of blood clot formation in chronic kidney disease patients and ultimately be targeted for therapeutic purposes.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications for its stem cell research and drug discovery tool StemDisc have been filed.
› Verified 8 days ago
| Entity Name | Pennyroyal Healthcare Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124319942 PECOS PAC ID: 6002076700 Enrollment ID: O20120404000101 |
News Archive
Asthma is the most common chronic illness and is responsible for 2.1 million emergency room visits annually. But according to a study being presented at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology, these costly visits can be reduced by 55 percent when inhalers contain a simple dose counter.
Researchers at the University of Pennsylvania School of Medicine are now studying an investigational treatment that may offer a significant new, minimally-invasive option for those suffering from advanced widespread emphysema.
Researchers at the Case Western Reserve University School of Medicine have identified that a gene critical to clearing up unnecessary proteins plays a role in brain development and contributes to the development of autism spectrum disorders and schizophrenia.
Researchers have identified a potential new signaling pathway and enzyme that may help further the understanding of blood clot formation in chronic kidney disease patients and ultimately be targeted for therapeutic purposes.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications for its stem cell research and drug discovery tool StemDisc have been filed.
› Verified 8 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
Asthma is the most common chronic illness and is responsible for 2.1 million emergency room visits annually. But according to a study being presented at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology, these costly visits can be reduced by 55 percent when inhalers contain a simple dose counter.
Researchers at the University of Pennsylvania School of Medicine are now studying an investigational treatment that may offer a significant new, minimally-invasive option for those suffering from advanced widespread emphysema.
Researchers at the Case Western Reserve University School of Medicine have identified that a gene critical to clearing up unnecessary proteins plays a role in brain development and contributes to the development of autism spectrum disorders and schizophrenia.
Researchers have identified a potential new signaling pathway and enzyme that may help further the understanding of blood clot formation in chronic kidney disease patients and ultimately be targeted for therapeutic purposes.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications for its stem cell research and drug discovery tool StemDisc have been filed.
› Verified 8 days ago
| Entity Name | Fast Pace Kentucky Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457716706 PECOS PAC ID: 0143525998 Enrollment ID: O20160216002913 |
News Archive
Asthma is the most common chronic illness and is responsible for 2.1 million emergency room visits annually. But according to a study being presented at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology, these costly visits can be reduced by 55 percent when inhalers contain a simple dose counter.
Researchers at the University of Pennsylvania School of Medicine are now studying an investigational treatment that may offer a significant new, minimally-invasive option for those suffering from advanced widespread emphysema.
Researchers at the Case Western Reserve University School of Medicine have identified that a gene critical to clearing up unnecessary proteins plays a role in brain development and contributes to the development of autism spectrum disorders and schizophrenia.
Researchers have identified a potential new signaling pathway and enzyme that may help further the understanding of blood clot formation in chronic kidney disease patients and ultimately be targeted for therapeutic purposes.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications for its stem cell research and drug discovery tool StemDisc have been filed.
› Verified 8 days ago
| Entity Name | Baptist Health Deaconess Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437730942 PECOS PAC ID: 6103220330 Enrollment ID: O20210810000993 |
News Archive
Asthma is the most common chronic illness and is responsible for 2.1 million emergency room visits annually. But according to a study being presented at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology, these costly visits can be reduced by 55 percent when inhalers contain a simple dose counter.
Researchers at the University of Pennsylvania School of Medicine are now studying an investigational treatment that may offer a significant new, minimally-invasive option for those suffering from advanced widespread emphysema.
Researchers at the Case Western Reserve University School of Medicine have identified that a gene critical to clearing up unnecessary proteins plays a role in brain development and contributes to the development of autism spectrum disorders and schizophrenia.
Researchers have identified a potential new signaling pathway and enzyme that may help further the understanding of blood clot formation in chronic kidney disease patients and ultimately be targeted for therapeutic purposes.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications for its stem cell research and drug discovery tool StemDisc have been filed.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hunter W Davis, MD Po Box 2400, Hopkinsville, KY 42241-2400 Ph: (270) 707-2100 | Hunter W Davis, MD 223 Burley Ave, Hopkinsville, KY 42240 Ph: (270) 887-6565 |
News Archive
Asthma is the most common chronic illness and is responsible for 2.1 million emergency room visits annually. But according to a study being presented at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology, these costly visits can be reduced by 55 percent when inhalers contain a simple dose counter.
Researchers at the University of Pennsylvania School of Medicine are now studying an investigational treatment that may offer a significant new, minimally-invasive option for those suffering from advanced widespread emphysema.
Researchers at the Case Western Reserve University School of Medicine have identified that a gene critical to clearing up unnecessary proteins plays a role in brain development and contributes to the development of autism spectrum disorders and schizophrenia.
Researchers have identified a potential new signaling pathway and enzyme that may help further the understanding of blood clot formation in chronic kidney disease patients and ultimately be targeted for therapeutic purposes.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications for its stem cell research and drug discovery tool StemDisc have been filed.
› Verified 8 days ago
Kari Howton, APRN Family Medicine Medicare: Medicare Enrolled Practice Location: 1724 Kenton St Ste 1d, Hopkinsville, KY 42240 Phone: 270-887-9066 Fax: 270-887-9199 | |
Alan D Cato, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2400 Russellville Rd, Hopkinsville, KY 42240 Phone: 270-889-6025 Fax: 270-886-4487 | |
Dr. Panagiotis Galanopoulos, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3999 Fort Campbell Blvd, Hopkinsville, KY 42240 Phone: 270-886-2205 Fax: 270-886-0392 | |
Vinna R Denison, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 North Dr, Hopkinsville, KY 42240 Phone: 270-707-0303 Fax: 270-707-0808 | |
Billy Kevin Fralish, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Clinic Dr, Hopkinsville, KY 42240 Phone: 270-707-3300 | |
Dr. William E Sweet, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1102 S Virginia St, Hopkinsville, KY 42240 Phone: 270-890-0440 Fax: 270-890-0449 | |
Chester L Crump, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1717 High St, Suite 2d, Hopkinsville, KY 42240 Phone: 270-885-6101 Fax: 270-885-3563 |